Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

XENLETA

LEFAMULIN ACETATE

Standard Dose
EQ 150MG BASE/15ML (EQ 10MG BASE/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview XENLETA is listed in Drugs@FDA under application 211673 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient LEFAMULIN ACETATE Form and strength SOLUTION;INTRAVENOUS - EQ 150MG BASE/15ML (EQ 10MG BASE/ML) Sponsor HONG KONG Submission history Latest submission status date: 2021-03-16 00:00:00.

Structured Monograph

Clinical summary

Approval overview XENLETA is listed in Drugs@FDA under application 211673 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient LEFAMULIN ACETATE Form and strength SOLUTION;INTRAVENOUS - EQ 150MG BASE/15ML (EQ 10MG BASE/ML) Sponsor HONG KONG Submission history Latest submission status date: 2021-03-16 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.